001     909608
005     20240116084313.0
024 7 _ |a 10.1016/j.neurom.2022.01.013
|2 doi
024 7 _ |a 1094-7159
|2 ISSN
024 7 _ |a 1525-1403
|2 ISSN
024 7 _ |a 10.34734/FZJ-2022-03280
|2 datacite_doi
024 7 _ |a 35219570
|2 pmid
024 7 _ |a WOS:000932773400001
|2 WOS
037 _ _ |a FZJ-2022-03280
082 _ _ |a 610
100 1 _ |a Jergas, Hannah
|0 P:(DE-HGF)0
|b 0
|e Corresponding author
245 _ _ |a Brain Morphometry Associated With Response to Levodopa and Deep Brain Stimulation in Parkinson Disease
260 _ _ |a Amsterdam
|c 2023
|b Elsevier
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1701775859_31575
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a ObjectivesWhether treatment response in patients with Parkinson disease depends on brain atrophy is insufficiently understood. The goal of this study is to identify specific atrophy patterns associated with response to dopaminergic therapy and deep brain stimulation.Materials and MethodsIn this study, we analyzed the association of gray matter brain atrophy patterns, as identified by voxel-based morphometry, with acute response to levodopa (N = 118) and subthalamic nucleus deep brain stimulation (N = 39). Motor status was measured as a change in points on the Unified Parkinson’s Disease Rating Scale III score. Baseline values were obtained before surgery, after cessation of dopaminergic medication for at least 12 hours; response to medication was assessed after administration of a standardized dose of levodopa. Response to deep brain stimulation was measured three months after surgery in the clinical condition after withdrawal of dopaminergic medication.ResultsAlthough frontoparietal brain gray matter loss was associated with subpar response to deep brain stimulation, there was no significant link between brain atrophy and response to levodopa.ConclusionWe conclude that response to deep brain stimulation relies on gray matter integrity; hence, gray matter loss may present a risk factor for poor response to deep brain stimulation and may be considered when making decision regarding clinical practice.
536 _ _ |a 5251 - Multilevel Brain Organization and Variability (POF4-525)
|0 G:(DE-HGF)POF4-5251
|c POF4-525
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Petry-Schmelzer, Jan Niklas
|0 P:(DE-HGF)0
|b 1
700 1 _ |a Dembek, Till A.
|0 P:(DE-HGF)0
|b 2
700 1 _ |a Dafsari, Haidar S.
|0 P:(DE-HGF)0
|b 3
700 1 _ |a Visser-Vandewalle, Veerle
|0 P:(DE-HGF)0
|b 4
700 1 _ |a Fink, Gereon R.
|0 P:(DE-Juel1)131720
|b 5
700 1 _ |a Baldermann, Juan Carlos
|0 P:(DE-HGF)0
|b 6
700 1 _ |a Barbe, Michael T.
|0 P:(DE-Juel1)131613
|b 7
773 _ _ |a 10.1016/j.neurom.2022.01.013
|g p. S1094715922000344
|0 PERI:(DE-600)2008283-6
|n 2
|p 340-347
|t Neuromodulation
|v 26
|y 2023
|x 1094-7159
856 4 _ |y Restricted
|u https://juser.fz-juelich.de/record/909608/files/PDF%20RESTRICTED%20.pdf
856 4 _ |y Published on 2023-02-24. Available in OpenAccess from 2024-02-24.
|u https://juser.fz-juelich.de/record/909608/files/post-print.docx.pdf
856 4 _ |y Restricted
|x icon
|u https://juser.fz-juelich.de/record/909608/files/PDF%20RESTRICTED%20.gif?subformat=icon
856 4 _ |y Restricted
|x icon-1440
|u https://juser.fz-juelich.de/record/909608/files/PDF%20RESTRICTED%20.jpg?subformat=icon-1440
856 4 _ |y Restricted
|x icon-180
|u https://juser.fz-juelich.de/record/909608/files/PDF%20RESTRICTED%20.jpg?subformat=icon-180
856 4 _ |y Restricted
|x icon-640
|u https://juser.fz-juelich.de/record/909608/files/PDF%20RESTRICTED%20.jpg?subformat=icon-640
856 4 _ |y Published on 2023-02-24. Available in OpenAccess from 2024-02-24.
|x icon
|u https://juser.fz-juelich.de/record/909608/files/post-print.gif?subformat=icon
856 4 _ |y Published on 2023-02-24. Available in OpenAccess from 2024-02-24.
|x icon-1440
|u https://juser.fz-juelich.de/record/909608/files/post-print.jpg?subformat=icon-1440
856 4 _ |y Published on 2023-02-24. Available in OpenAccess from 2024-02-24.
|x icon-180
|u https://juser.fz-juelich.de/record/909608/files/post-print.jpg?subformat=icon-180
856 4 _ |y Published on 2023-02-24. Available in OpenAccess from 2024-02-24.
|x icon-640
|u https://juser.fz-juelich.de/record/909608/files/post-print.jpg?subformat=icon-640
909 C O |o oai:juser.fz-juelich.de:909608
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 5
|6 P:(DE-Juel1)131720
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|9 G:(DE-HGF)POF4-5251
|x 0
914 1 _ |y 2023
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2022-11-22
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2022-11-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2022-11-22
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEUROMODULATION : 2022
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-22
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-22
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2023-10-22
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-3-20090406
|k INM-3
|l Kognitive Neurowissenschaften
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-3-20090406
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21